$CDLX

CDLX (NASDAQ: CDLX) files Form 144 for 40,296-share resale tied to vesting

Cardlytics, Inc. (NASDAQ: CDLX) has filed Form 144, indicating a proposed resale of 40,296 shares of Common Stock. This resale is linked to Restricted Stock Vesting that occurred on March 31, 2026. The filing also notes a previous sale of 6,253 shares by Nicholas H. Lynton on January 5, 2026.

Original reporting
Published Apr 1, 2026, 7:47 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Apr 1, 2026, 8:30 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$CDLX
Neutral
medium confidence
Mentioned
$CDLX
alphai data visualization · based on Stock Titan
Decision brief

The 30-second read

$CDLXNeutralMed
01

Why it matters

The insider resale may temporarily increase stock supply, potentially leading to a short-term price decline. Market perception will depend on broader investor sentiment and overall trading volume.

02

Market read

While the insider sale is noteworthy, it is a routine event and unlikely to cause significant long-term impact unless accompanied by other negative signals.

03

What to watch

Market conditions, overall sector performance, and upcoming company fundamentals or earnings reports could mitigate or amplify the impact of insider activity.

Timing: Immediate (within days)

Background

Cardlytics filed Form 144 indicating the sale of 40,296 shares, linked to vesting events that occurred on March 31, 2026. This follows a previous sale of 6,253 shares by Nicholas H. Lynton on January 5, 2026.

Company-level read

Ticker impact

$CDLXNeutralMedium confidence
Context

The filing indicates insider activity related to stock vesting and potential resale, which can influence stock supply and investor perception.

Expected impact

Moderate short-term decline of approximately 2-4%, depending on market conditions.

Evidence & confidence

Insider sales tied to vesting are common and do not necessarily indicate negative outlooks; however, increased supply can influence price dynamics, especially if accompanied by low trading volume.

Market effects

Potential short-term pressure on the technology and financial services sectors if multiple insider sales occur.

Limited; primarily affects the NASDAQ and related regional indices.

Negligible; the event is company-specific and does not impact global markets.

Counterpoint

Insider sales tied to vesting may be routine and not indicative of negative sentiment; the stock could remain stable or rebound after initial sell-off.

Key entities

  • Cardlytics, Inc.

    A marketing technology company that provides purchase intelligence and marketing automation solutions.

  • Nicholas H. Lynton

    A director or executive of Cardlytics involved in the previous sale.

Related articles

$CDLXMedAI 8/10

Cardlytics: Q2 Earnings Snapshot

Cardlytics (CDLX) reported a Q2 loss of $14.9 million, or $2.58 per share. Adjusted for discontinued operations, the loss was $1.50 per share. Revenue was $36.9 million. For the quarter ending September, the company expects revenue of $34 million to $39 million.

$CDLXMed

Cardlytics, Inc. (CDLX): Results of Operations and Financial Condition

Cardlytics, Inc. (CDLX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 cdlx_form8-kx2026q2xex991.htm EX-99.1 Document Exhibit 99.1 Cardlytics Second Quarter 2026 Financial Results Driven By Strong Operational Performance • Company delivers strong second quarter results: ◦ Revenues of $36.9 million ◦ Billings of $65.5 million ◦ Adjusted Con

$ETNMed

Eaton Gains on $7-Million Contract

Eaton (NYSE:ETN) said the U.S. Air Force Research Laboratory awarded it a $7 million, 24-month contract to use quantum computing, machine learning, and advanced visualization to improve power grid resilience and protection. The work, with Infleqtion and Penn State, targets detection and response to multiple concurrent physical and cyber threats, addressing NERC N-2 contingency requirements.

$XOMMed

ExxonMobil awards McDermott engineering work for Rovuma LNG

ExxonMobil Moçambique Limitada issued McDermott Energy Solutions (UK) a letter of intent for limited engineering and procurement work on Rovuma LNG Phase 1 midstream development. The award supports planning ahead of a final investment decision expected in 2026. Rovuma LNG targets 12 modular trains totaling 18.6 mtpa, with start-up in 2031. ExxonMobil says the 30-year project could generate about $150B in revenues for Mozambique’s government.

$ESLTMed

Serbia to open joint UAV factory with Elbit in September

Serbia President Aleksandar Vucic said Serbia will open a joint UAV factory with Elbit Systems, with inauguration expected Sept 15-20. Elbit will hold 51% and Serbia’s state arms firm SDPR 49%. The factory relates to a five-year contract covering precision rockets and unmanned systems, plus ISTAR, digitization and upgrades.

$NOCMed

The Pentagon is urging defense contractors to urgently ramp up weapons production – WP

The U.S. Department of Defense, according to The Washington Post, asked defense contractors to submit within 21 days production and delivery schedules for critical systems, citing depleted stockpiles. CSIS estimates cite heavy early use of missiles and falling Patriot and THAAD inventories. The Pentagon is working with Northrop Grumman and Lockheed Martin, including a $58.6B deal to triple PAC-3 output by 2030, pending a stalled $1.15T defense budget.